Dr. Sanjay S. Reddy Promoted to Division Chief of Surgical Oncology at Fox Chase Cancer Center

Sanjay S. Reddy, MD, FACS, Co-Director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute, has been promoted to Division Chief of Surgical Oncology.

PHILADELPHIA (July 22, 2024) - Sanjay S. Reddy, MD, FACS, an Associate Professor in the Department of Surgery, Program Director of the Complex General Surgical Oncology Fellowship, and Co-Director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute, has been promoted to Division Chief of Surgical Oncology at Fox Chase Cancer Center.

Since joining Fox Chase in 2012, Reddy has been a pivotal leader in the growth of not only the division, but also the institution. He has established himself as a preeminent leader in pancreatic cancer care and built a high-volume clinical program in the Philadelphia region. He has also been an integral part of a dynamic team dedicated to advancing the field and providing exceptional patient care. In addition to his other titles, last June he was appointed as the Marvin S. Greenberg, MD, Chair in Pancreatic Cancer Surgery, making him the youngest endowed chair in Fox Chase history.

"Over the years, we have assembled a group of individuals with a strong background in oncology, advanced surgical techniques, and a passion for providing comprehensive cancer care, which Dr. Reddy has embraced since his time as a fellow," said Jeffrey Farma, MD, FACS, Chair of Surgery.

Reddy has already established himself as a leader at the institution, having served multiple leadership roles. "He is the Gastrointestinal Service Line Clinical Director, which establishes close collaboration with other departments such as medical oncology and radiation oncology. This multidisciplinary approach ensures a comprehensive and coordinated cancer care plan for patients. Dr. Reddy has played an essential role in not only the growth of the Marvin & Concetta Greenberg Pancreatic Cancer Institute but also in the leadership of the Complex General Surgical Oncology Fellowship," Farma said.

Reddy and the co-leaders of the Greenberg Institute have assembled a translational program utilizing the best minds that Fox Chase has to offer, work that will continue to push divisional growth in cancer care to the next level. "With Dr. Reddy's new position as Division Chief, I have no doubt that his expertise in multiple forms of oncologic surgery and leadership skills will continue to be an asset to Fox Chase's future," Farma added.

Reddy first joined Fox Chase for a two-year fellowship in complex general surgical oncology and was appointed Assistant Professor in 2014. In 2018, he was promoted to Associate Professor.

He has multiple peer-reviewed publications and serves on regional and national committees through the American College of Surgeons, the Society of Surgical Oncology, and the Association of Academic Surgery, in addition to several others. He is a thought leader in promoting neoadjuvant therapy for pancreatic cancer and has been a leader on several investigator-initiated clinical trials in this area.

On a regional scale, he has been heavily involved with the Metropolitan Chapter of the American College of Surgeons and currently serves as a member-at-large. He has co-chaired the citywide Mock Oral Board Examination, one of the largest mock examinations of its kind in the nation, for five consecutive years.

Nationally, he serves as an Editorial Board Member for the Education and Training section for Surgical Oncology Insight, which is a part of the Society of Surgical Oncology's signature journal, Annals of Surgical Oncology. He is also heavily involved in fellowship training with the Society of Surgical Oncology's leadership, which is supported by his recent appointment to the Complex General Surgical Oncology Board's Entrustable Professional Activities Scope Council. This is an intensive two-year commitment to developing a structured curriculum to improve surgical education.

As a clinician, his reputation in the region as a compassionate, highly skilled, and kind physician is well known. He was named a 2023 Top Doctor by Philadelphia magazine, a Top Physician Under 40 in 2020 by the Pennsylvania Medical Society (PAMED), received a leadership grant through PAMED to further develop his leadership skills, and was recently awarded the SSO Career Catalyst Mentorship Program Award.

Despite these accomplishments, he continues to balance his clinical and academic responsibilities. "Dr. Reddy's transition into this new role is a well-deserved accomplishment, and I cannot think of a better suited colleague and friend for this position," said Farma.